When Can We Expect a COVID-19 Vaccine? | Amanpour and Company

With coronavirus spiking around the world amid easing lockdowns, the need for a viable vaccine grows more urgent. In the global scientific rush, Russia is the latest to claim its vaccine will soon be approved -- although no testing data has been released, prompting concerns about adequate precautions. Right now there are more than 165 vaccines in development, with 27 already in human trials. Carl Zimmer is an award-winning science writer with a weekly column in the New York Times, and he speaks with Walter Isaacson to break down the biology.

Originally aired on July 29, 2020.

Subscribe to the Amanpour and Company. channel here: https://bit.ly/2EMIkTJ

For more from Amanpour and Company, including full episodes, click here: https://to.pbs.org/2NBFpjf

Like Amanpour and Company on Facebook: https://bit.ly/2HNx3EF

Follow Amanpour and Company on Twitter: https://bit.ly/2HLpjTI

Watch Amanpour and Company weekdays on PBS (check local listings).

Amanpour and Company features wide-ranging, in-depth conversations with global thought leaders and cultural influencers on the issues and trends impacting the world each day, from politics, business and technology to arts, science and sports. Christiane Amanpour leads the conversation on global and domestic news from London with contributions by prominent journalists Walter Isaacson, Michel Martin, Alicia Menendez and Hari Sreenivasan from the Tisch WNET Studios at Lincoln Center in New York City.

#amanpourpbs

Видео When Can We Expect a COVID-19 Vaccine? | Amanpour and Company канала Amanpour and Company